VNRX News and Press, VolitionRX Limited From 11/04/21

Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference PR Newswire Positive data show Nu.Q ® can be used to monitor for disease response and progression including remission monitoring in cancer bearing dogs. Paves the way...

VolitionRx Ltd. (NYSE American: VNRX) is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve t...

NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will showcase live company presentations an...

VolitionRx Ltd. (NYSE American: VNRX) is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve the...

LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The SNN Network Summer Virt...

Image source: The Motley Fool. VolitionRX Ltd (NYSEMKT: VNRX) Q2 2021 Earnings Call Aug 12, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: VolitionRX Ltd (VNRX) Q2 2021 Earnings Call Transcript

VolitionRx Limited (VNRX) Q2 2021 Results Conference Call August 12, 2021 08:00 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Terig Hughes - Chief Financial Officer Thomas Butera - Chief Execut...

The following slide deck was published by VolitionRx Limited in conjunction with their 2021 Q2 earnings call. For further details see: VolitionRx Limited 2021 Q2 - Results - Earnings Call Presentation

VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Thursday, August 12, at 8:00 a.m. U.S. Eastern Time PR Newswire Strong balance sheet with approximately...

VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update Conference call to take place Thursday, August 12, 2021 at 8:00 am Eastern time PR Newswire AUSTIN, Texas , Aug. 4, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AME...